Levity Highlights Prescription weight loss medications Monthly medication shipment Online medical consultations Ongoing clinical support LegitScript certification Levity Mounjaro Review Mounjaro (Tirzepatide) is an injectable medication combining GLP-1 and GIP hormones, offered through Levity's telehealth weight loss program
The standard diluent for reconstituting lyophilised peptides in research settings, providing multi-use stability that sterile water or plain water cannot offer
Paul Holmes Director of Science and Innovation at Naturecan Testing for large pharmaceutical & tobacco companies, Paul has built a wealth of scientific and regulatory knowledge, working on regulatory submissions to bodies such as the FDA and the MHRA
GLP-1 receptors are present not only in the pancreas but also extensively throughout the gastrointestinal system
and European healthcare and consumer companies
Tirzepatide works by: Slowing gastric emptying , which prolongs the feeling of fullness after meals Reducing appetite through effects on brain centres that regulate hunger Improving insulin secretion in response to elevated blood glucose Decreasing glucagon secretion , which helps lower blood sugar levels Clinical trials have demonstrated that tirzepatide can lead to substantial weight losswith dose-dependent reductions of approximately 1520% of body weight over 72 weekswhen combined with lifestyle modifications